Trinity Capital Inc. Provides $30 Million in Growth Capital to Elucent Medical

Company Overview - Trinity Capital Inc. is a leading alternative asset manager focused on providing stable returns through private credit market investments [4] - Elucent Medical is a pioneering medical technology company specializing in guided surgical technologies aimed at improving patient outcomes [5] Investment Details - Trinity Capital announced a commitment of $30 million in growth capital to Elucent Medical [1] - This investment follows Elucent's earlier Series C funding round in 2024, where the company raised$44 million [3] Technology and Innovation - Elucent Medical's EnVisio® System utilizes In-Body Spatial Intelligence™ to enhance surgical precision by providing 3D awareness to surgeons [2] - The system integrates SmartClip® markers and SmartSensor™ technology to guide soft-tissue surgical excision, redefining surgical accuracy [2][5] Strategic Goals - Elucent Medical aims to scale operations and accelerate innovation and commercialization efforts with the new capital from Trinity Capital [3] - The company is committed to driving advancements in surgical oncologic care, positively impacting both patients and medical professionals [5]